news & events
portfolio news
06.09.17
AELIX Therapeutics enrolls first patient in company’s initial therapeutic HIV vaccine clinical trial
05.09.17
TiGenix obtains commercial production license for expanded manufacturing facility
21.07.17
Kala Pharmaceuticals Announces Pricing of Initial Public Offering
10.07.17
Prexton announces initiation of phase II clinical testing in Parkinson’s disease
05.07.17
Matthew Gantz Appointed CEO of Oxthera
30.06.17
Babyscripts Raises $5.7 Million to Build the Market’s Most Robust, Clinically-Validated Virtual Care Women’s Health Platform
19.06.17
Takeda and TiGenix announce that Swissmedic has accepted for review the file on Cx601 for the treatment of complex perianal fistulas in Crohn’s disease patients
15.06.17
TiGenix Partners with U.S. and European Patient Advocacy Groups Focused on Crohn’s Disease and Ulcerative Colitis
13.06.17
TiGenix Launches Global Phase III Trial for Cx601
12.06.17
TiGenix announces final equity payment for cardiac platform acquisition
